Market research
000504.SHE NanHua Bio-medicine Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- 69.33
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.39
Community
Investor discussion
1 comment
Sign in to join the 000504.SHE discussion.
5 years, 5 months ago
NanHua Bio-medicine Co., Ltd is currently in a long term uptrend where the price is trading 43.7% above its 200 day moving average.
From a valuation standpoint, the stock is 122.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.4.
NanHua Bio-medicine Co., Ltd's total revenue rose by 61.4% to $71M since the same quarter in the previous year.
Its net income has dropped by 70.0% to $12M since the same quarter in the previous year.
Finally, its free cash flow fell by 1229.1% to $-204M since the same quarter in the previous year.
Based on the above factors, NanHua Bio-medicine Co., Ltd gets an overall score of 2/5.